INTRODUCTION
============

New surgical methods have been developed in the field of liver transplantation to overcome organ shortage such as split liver organ, living donor, and reduced size \[[@B1]\]. Living donor liver transplantation (LDLT) is a volunteer action in which a healthy person denotes a fragment of his or her healthy liver to a liver recipient \[[@B2], [@B3]\]. A review article in 2015 reported a morbidity rate of 8.6% to 59% and a mortality rate of 0.2% among LDLT donors. The most common complication for donors was biliary complication and biliary leak \[[@B4]\]. The most commonly reported complications among living donors were in Clavien grades 1 and 2 \[[@B5], [@B6]\].

A study from China showed temporary abnormalities in liver function test and blood count among many of 300 living donors. While laboratory tests could be used to identify some post-operation complications, they are not useful to detect some physical, mental, and psychological difficulties, which mostly influence the quality of life of the donors after transplantation \[[@B7]\]. Nor can we evaluate the donor physical and psychological health solely based on common measured surgical factors\[[@B5]\]. Health-related quality of life is assessed in various ways, and influenced by several factors. One way to measure the quality of life is using questionnaires such as the Short Form (SF)-36 Health Survey \[[@B8], [@B9]\].

One study showed the Physical Component Score (PCS) decreased immediately after donation, then returned to the baseline within 6--12 months, while the Mental Component Score (MCS) remains comparable to that of normative population throughout the procedure \[[@B4], [@B10]\].

Living donors may experience various complications that are usually mild and have a good prognosis \[[@B11]\]. The probable effect of LDLT on the wellbeing of the donor and the psychological difficulties they might experience should be understood. We, therefore, conducted this study to assess the quality of life of living donors post liver-donation surgery.

METHODS AND MATERIALS
=====================

We retrospectively reviewed data of donors who underwent hepatectomy for liver transplantation at Shiraz Organ Transplant Center from 2012 to 2015. In census way, a total of 140 living donors underwent hepatectomy during this period. In the course of the donor evaluation process, all patients gave their informed written consent to participate in the follow-up studies. Our study was approved by the Ethical Committee of Shiraz University of Medical Sciences. The donors were asked to complete a data collecting form and the SF-36 through face to face or by telephone interview. The self-administered SF-36 survey assesses eight health domains: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH). Component analyses showed that there are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS); and a mental dimension, represented by the Mental Component Summary (MCS). The eight subscales are summarized by PCS and the MCS. The SF-36 score for each question ranged from 0 to 100 with higher score representative of better function. The general population average is 50 with a standard deviation of 10 \[[@B12]\]. We classified post-operative complications among liver donors according to the Clavien system ([Table 1](#T1){ref-type="table"}).

###### 

Classification of complications according to the Clavien system

  Grade   Complication
  ------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1       Any deviation from the normal post-operative course without the need for pharmacological treatment or surgical, endoscopic, and radiological interventions. Allowed therapeutic regimens are drugs as antiemetics, antipyretics, analgesics, diuretics, electrolytes, and physiotherapy. This grade also includes wound infections opened at the bedside.
  2       Complications requiring pharmacological treatment with drugs other than such allowed for grade 1 complications. Blood transfusions and total parenteral nutrition are also included.
  3       Complications requiring surgical, endoscopic, or radiological intervention
  3a      Intervention not under general anesthesia
  3b      Intervention under general anesthesia
  4       Life-threatening complications (including central nervous system complications) requiring intensive care unit stay
  4a      Single organ dysfunction (including dialysis)
  4b      Multiorgan dysfunction
  5       Death of the patient

Most of the additional data used for analysis were obtained by chart review, anesthesia records, and the computerized hospital database. Continues variables were expressed as mean±SD; categorical variables, number (percent). Student's t test for independent samples, one-way ANOVA, and Person's correlation coefficient were used for data analysis. A p value \<0.05 was considered statistically significant.

Results
=======

Donor Characteristics

The mean±SD age of donors at transplantation time was 32.1±7.3 (range: 17--65) years; 83 (59.3%) of them were female. Most of the donors (n=134, 95.7%) were married. About one-third (n=45, 32.2%) of donors had a diploma and higher education. Among our participants, 61 (43.6%) were employed. The mean±SD for Body Mass Index (BMI) was 23.8±3.5 (kg/m^2^). "Mother-to-child" (n=79, 56.4%) was the most frequent relationship. More than 90% of our participants were volunteers to donate again and recommend LDLT to somebody else; to be exact, 91.8% and 91.7%, respectively ([Table 2](#T2){ref-type="table"}).

###### 

Donors characteristics. Values are either mean±SD or n (%)

  Variables                          Statistics        
  ---------------------------------- ----------------- ------------
  Age, yrs                           32.1±7.3          
  Body mass index, kg/m^2^           23.8±3.5          
  Sex                                Male              57 (40.7)
  Female                             83 (59.3)         
  Marital status                     Married           134 (95.7)
  Others                             6 (4.3)           
  Education                          Illiterate        4 (2.9)
  Primary school                     27 (19.3)         
  Secondary school                   28 (20.0)         
  High school                        36 (25.7)         
  Diploma and higher                 45 (32.2)         
  Employment                         Employed          61 (43.6)
  Unemployed                         74 (52.9)         
  Pensioned                          5 (3.5)           
  Ethnicity                          Fars              92 (65.7)
  Arab                               14 (10.0)         
  Turk                               12 (8.6)          
  Kurd                               10 (7.1)          
  Lor                                4 (2.9)           
  Balooch                            1 (0.7)           
  Others                             7 (5.0)           
  Relationship to recipient          Mother            79 (56.4)
  Father                             49 (35.0)         
  First relative(grand-uncle-aunt)   5 (3.6)           
  Daughter                           4 (2.9)           
  Spouse                             1 (0.7)           
  Others(second degree relatives)    2 (1.4)           
  First learned about LDLT           Transplant team   98 (70.5)
  General physician                  18 (12.9)         
  Family                             15 (10.8)         
  Others                             8 (5.7)           
  Source of income                   Sick leave        11 (7.9)
  Savings                            56 (40.0)         
  Others                             73 (52.1)         

Operative Details and Outcomes

Among 140 living liver donors, 75 (72.0%) underwent left lateral; 24 (23.1%), left lobe; and 5 (4.8%), right hepatectomy. The mean±SD of operative time was 233.8±46.9 min. The mean±SD of hospital stay and ICU stay were 4.4±2.3 and 2.8±0.9 days, respectively. There was no death among our donors. Twenty-two (15.7%) complications were recorded among our participants. The intra-operative data of all the donors were collected retrospectively ([Table 3](#T3){ref-type="table"}).

###### 

Intra- and post-operative characteristics of studied donors. Values are either mean±SD or n (%).

  Characteristic                                             Statistics                                      
  ---------------------------------------------------------- ----------------------------------------------- -----------
  Mode of donor hepatectomy                                  Left lateral                                    75 (72.0)
  Left lobe                                                  24 (23.1)                                       
  Right lobe                                                 5 (4.8)                                         
  Pre-operative biochemical profile                          Total bilirubin, µmol/L                         0.9±0.5
  Alkaline phosphatase, IU/L                                 183.9±61.9                                      
  Hemoglobin, g/dL                                           14.0±1.8                                        
  Post-operative biochemical profile                         Total bilirubin, µmol/L                         1.7±0.9
  Alkaline phosphatase, IU/L                                 152.7±50.4                                      
  Hemoglobin, g/dL                                           12.2±1.7                                        
  Operation time, min                                        233.8±46.9                                      
  ICU stay, day                                              2.8±0.9                                         
  Mean hospital stay, day                                    4.4±2.3                                         
  Mean complete recovery time, month                         3±1.4                                           
  Post-operative complications according to Clavien system   22 (15.7)                                       
  Grade 1(n=7, 31.81%)                                       Fever of unknown origin                         1 (5)
  Atelectasis                                                3 (13.6)                                        
  Neuropraxia                                                1 (5)                                           
  Mild pleural effusion treated conservatively               2 (9)                                           
  Grade 2 (n=7, 31.81%)                                      Wound infection requiring antibiotics           6 (27.3)
  Blood transfusion                                          1 (5)                                           
  Grade 3A (n=4, 18.18%)                                     Intra-abdominal abscess                         1 (5)
  Bile stricture                                             1 (5)                                           
  Bile leakage treated with percutaneous drainage, ERCP      2 (9)                                           
  Grade 3B(n=4, 18.18%)                                      Intra-abdominal bleeding requiring laparotomy   4 (18.2)
  Grade 4A                                                   0 (0)                                           
  Grade 4B                                                   0 (0)                                           
  Grade 5                                                    0 (0)                                           

SF-36 Results

The mean±SD of PCS and MCS scores were 48.8±14.6 and 50.1±6.9, respectively ([Table 4](#T4){ref-type="table"}). Improvement was reported by 131 (93.6%) recipients; 9 (6.4%) died. There was significant (p=0.011) relationship between the recipient outcome and donors' PCS. No significant (p=0.449) relationship was observed between the recipient outcome and donors' MCS score. There was no significant correlation between age and the quality of life scales measured.

###### 

Comparison of mean±SD of SF-36 scores between living liver donors and general population of Iran

  Scales   Our study (n=140)   Ali Montazeri, *et al* (n=4163)   p value
  -------- ------------------- --------------------------------- ---------
  PF       70.4±19.1           85.3±20.8                         \<0.001
  RP       73.0±48.3           70.0±38.0                         0.363
  BP       78.5±23.1           79.4±25.1                         0.675
  GH       53.1±12.9           67.5±20.4                         \<0.001
  VT       45.8±10.6           65.8±17.3                         \<0.001
  SF       79.0±19.6           76.0±24.4                         0.152
  RE       76.6±49.7           65.5±41.4                         0.002
  MH       43.9±9.3            67.0±18.0                         \<0.001
  PCS      48.8±14.6           ---                               ---
  MCS      50.1±6.9            ---                               ---

Males had a significantly higher scores in physical functioning scale compared with females. However, there was no significant difference in other scales between males and females. No significant difference was found in quality of life scales between employed and non-employed donors ([Table 5](#T5){ref-type="table"}).

###### 

The Effect of sex, education, and employment on the mean±SD SF-36 domains

  Scales   Education   p value     Sex         p value   Employed    p value                                     
  -------- ----------- ----------- ----------- --------- ----------- ----------- ------- ----------- ----------- -------
  PF       69.9±18.7   69.6±19.0   73.4±20.8   0.678     74.3±18.3   67.7±19.3   0.046   73.5±19.7   67.8±18.4   0.084
  RP       72.5±51.1   75.9±52.5   68.2±30.4   0.801     76.2±40.3   70.7±53.4   0.505   69.9±28.9   75.6±60.0   0.486
  BP       78.4±24.8   76.8±22.1   82.2±21.8   0.634     79.5±21.4   77.8±24.4   0.684   80.6±21.2   76.8±24.7   0.329
  GH       53.5±12.1   52.7±10.2   53.2±18.8   0.948     54.4±13.8   52.5±12.2   0.462   54.1±14.8   52.3±11.0   0.420
  VT       47.0±10.9   44.4±10.8   45.9±9.4    0.426     46.0±9.9    45.7±11.1   0.869   45.7±10.5   45.9±10.7   0.876
  SF       78.4±19.2   79.7±18.0   78.8±24.1   0.945     80.1±20.5   78.2±19.1   0.561   79.4±20.8   78.6±18.7   0.795
  RE       73.7±53.4   81.1±52.9   74.3±31.7   0.711     79.3±42.7   74.7±54.3   0.599   73.9±32.2   78.9±60.8   0.556
  MH       44.0±9.7    43.5±9.1    44.4±8.9    0.912     43.9±8.94   43.9±9.6    0.990   43.8±9.4    44.0±9.2    0.937
  PCS      48.2±14.4   48.9±14.8   50.2±15.0   0.937     51.2±13.8   47.2±14.9   0.109   50.1±14.0   47.8±15.0   0.349
  MCS      50.1±6.7    49.6±7.5    50.8±6.3    0.794     50.4±6.65   49.8±7.1    0.590   50.1±6.6    50.0±7.2    0.892

DISCUSSION
==========

One of main issues in liver transplantation is shortage of deceased donors. Using living donors is one of the solutions for this problem. However, one of the main items in this field is the health of donors \[[@B13], [@B14]\]. We studied the safety of living donor liver transplantation retrospectively based on different factors in the current study. A total of 15.7% of our participants experienced a complication; no death was reported.

Studies from different countries report various results. Post-operative complications occur in 28% of living liver donors in Brazil. The rate was 13.2 in Japan and 11.6% in Pakistan. No mortality was reported \[[@B15]-[@B17]\]. The reported wound infection and biliary complication rates were the same (5.9%) in Japan. The most common post-donation complications were bile leak, incisional hernia, pneumonia, and intra-abdominal collection in Pakistan \[[@B16], [@B17]\]. A systematic review on safety of living donors reported a donor mortality rate of 0.2%, and a median donor morbidity rate of 16% (range: 0%--100%). Biliary complications and infections were the most frequent complications \[[@B18]\]. A study from Japan on 28 donors showed that wound-related physical symptoms (24%) and anxiety (19%) were the common reported complications \[[@B19]\]. A study from South Asia reported an overall morbidity rate of 23%; wound infections (4.3%) was the most common complication \[[@B20]\]. Wound infection was the most common complication among our participants too. Using laparoscopic hepatectomy may reduce wound-related symptoms.

A study conducted in the US reported that of 740 LDLT (707 right lobes), 39% developed at least one complication in the first year \[[@B5]\]. Majority of donors in the US underwent right lobe hepatectomy that could explain the difference observed between their complication rate and ours.

The most complications of our studied donors were classified as Clavien grades 1 and 2, which was consistent with other studies \[[@B5], [@B6]\]. We found mean±SD scores of 48.8±14.6 for PCS and 50.1±6.9 for MCS. Post-operative donors PCS and MCS scores were almost near to the average of the general population in Iran \[[@B12], [@B21]\]. There were significant differences between domains of physical functioning, general health perceptions, vitality, emotional role functioning, general mental health obtained among donors in our study ([Table 4](#T4){ref-type="table"}) and those reported in general population in Iran \[[@B22]\].

Mental health and vitality scores were below the average in our study ([Table 4](#T4){ref-type="table"}). A study conducted in general population in Iran showed that mental health-related quality of life was lower than the physical health-related quality of life \[[@B12]\]. It could be due to the anxiety and depression before and after donation. On the other hand, the majority of donors were parents of recipients, which could explain this finding.

A review article reported that physical scores of quality of life decrease in the first three months after donation; they return back to the baseline within six months in the majority of donors. Mental scores are unaffected during the donation process \[[@B8], [@B19]\]. The results we obtained for PCS and MCS domains were almost near to those values reported three months after donation in another study \[[@B23]\]. The result of two cohort studies show that surgery-related complications do not significantly change the quality of life by itself in the majority of donors \[[@B3], [@B23]\].

Donation experience was positive among our participants. The majority (91.8%) of our donors volunteered to donate again. Living liver donors at the University of Minnesota shared the same sentiment \[[@B24]\].

A study shows that the majority of donors have a recovery time of one year \[[@B5]\]. Approximately one-third of our donors had post-donation follow-up less than one year at the time of study. This is a limitation of our study. We should have included donors with more than one-year post-donation follow-up too. Our study had other limitations. It was a cross-sectional study and thus we could not determine pre-donation SF-36 scores. Although all medical records were studied in detail, the accuracy of the results is not comparable with longitudinal studies. Given that the studied donors were from healthy population, it would have been better to design a longitudinal study and evaluate the quality of life of the donors before and after the donation.

In conclusion, most living donors sustain a quality of life near average of the general population after donation. This means that living donation does not negatively affect the quality of life of donors in Iran.
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